vs
Side-by-side financial comparison of AGENUS INC (AGEN) and SYPRIS SOLUTIONS INC (SYPR). Click either name above to swap in a different company.
AGENUS INC is the larger business by last-quarter revenue ($34.2M vs $30.3M, roughly 1.1× SYPRIS SOLUTIONS INC). SYPRIS SOLUTIONS INC runs the higher net margin — -12.9% vs -31.0%, a 18.1% gap on every dollar of revenue. On growth, AGENUS INC posted the faster year-over-year revenue change (27.5% vs -9.5%). Over the past eight quarters, AGENUS INC's revenue compounded faster (10.5% CAGR vs -7.7%).
Agenus Inc. is a Lexington, Massachusetts-based biotechnology company focused on immunotherapy including immuno-oncology, a field that uses the immune system to control or cure cancer. The company is developing checkpoint modulators (CPMs), patient-specific anti-cancer vaccines, and adjuvants designed for use with various vaccines. CPM development is a particularly fast-moving field, since early products have produced unprecedented clinical benefits for patients.
Sypris Solutions Inc. is a U.S.-headquartered provider of highly engineered components and specialized technical services, primarily serving aerospace, defense, automotive and commercial industrial markets. It delivers custom manufacturing, performance testing, and value-added engineering support for mission-critical systems and parts for global enterprise clients.
AGEN vs SYPR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $34.2M | $30.3M |
| Net Profit | $-10.6M | $-3.9M |
| Gross Margin | — | 4.6% |
| Operating Margin | 42.1% | -10.9% |
| Net Margin | -31.0% | -12.9% |
| Revenue YoY | 27.5% | -9.5% |
| Net Profit YoY | 77.3% | -2992.6% |
| EPS (diluted) | $0.09 | $-0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $34.2M | $30.3M | ||
| Q3 25 | $30.2M | $28.7M | ||
| Q2 25 | $25.7M | $31.4M | ||
| Q1 25 | $24.1M | $29.5M | ||
| Q4 24 | $26.8M | $33.4M | ||
| Q3 24 | $25.1M | $35.7M | ||
| Q2 24 | $23.5M | $35.5M | ||
| Q1 24 | $28.0M | $35.6M |
| Q4 25 | $-10.6M | $-3.9M | ||
| Q3 25 | $63.9M | $517.0K | ||
| Q2 25 | $-30.0M | $-2.1M | ||
| Q1 25 | $-26.4M | $-899.0K | ||
| Q4 24 | $-46.8M | $135.0K | ||
| Q3 24 | $-67.2M | $390.0K | ||
| Q2 24 | $-54.8M | $16.0K | ||
| Q1 24 | $-63.5M | $-2.2M |
| Q4 25 | — | 4.6% | ||
| Q3 25 | 97.9% | 7.2% | ||
| Q2 25 | 99.1% | 8.2% | ||
| Q1 25 | 99.4% | 11.4% | ||
| Q4 24 | 99.6% | 16.1% | ||
| Q3 24 | 99.4% | 16.8% | ||
| Q2 24 | 99.5% | 15.9% | ||
| Q1 24 | 99.6% | 8.1% |
| Q4 25 | 42.1% | -10.9% | ||
| Q3 25 | -15.0% | -6.1% | ||
| Q2 25 | -65.0% | -4.6% | ||
| Q1 25 | -55.3% | -0.4% | ||
| Q4 24 | -96.5% | 3.9% | ||
| Q3 24 | -125.5% | 4.8% | ||
| Q2 24 | -128.4% | 3.6% | ||
| Q1 24 | -117.4% | -3.9% |
| Q4 25 | -31.0% | -12.9% | ||
| Q3 25 | 211.4% | 1.8% | ||
| Q2 25 | -116.8% | -6.5% | ||
| Q1 25 | -109.6% | -3.0% | ||
| Q4 24 | -174.4% | 0.4% | ||
| Q3 24 | -267.7% | 1.1% | ||
| Q2 24 | -233.1% | 0.0% | ||
| Q1 24 | -226.6% | -6.2% |
| Q4 25 | $0.09 | $-0.17 | ||
| Q3 25 | $1.94 | $0.02 | ||
| Q2 25 | $-1.00 | $-0.09 | ||
| Q1 25 | $-1.03 | $-0.04 | ||
| Q4 24 | $-1.95 | $0.00 | ||
| Q3 24 | $-3.08 | $0.02 | ||
| Q2 24 | $-2.52 | $0.00 | ||
| Q1 24 | $-3.04 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.0M | — |
| Total DebtLower is stronger | $44.7M | — |
| Stockholders' EquityBook value | $-271.1M | $17.8M |
| Total Assets | $226.8M | $107.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.0M | — | ||
| Q3 25 | $3.5M | — | ||
| Q2 25 | $9.5M | — | ||
| Q1 25 | $18.5M | — | ||
| Q4 24 | $40.4M | — | ||
| Q3 24 | $44.8M | — | ||
| Q2 24 | $93.7M | — | ||
| Q1 24 | $52.9M | — |
| Q4 25 | $44.7M | — | ||
| Q3 25 | $34.2M | — | ||
| Q2 25 | $33.9M | — | ||
| Q1 25 | $33.6M | — | ||
| Q4 24 | $33.2M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-271.1M | $17.8M | ||
| Q3 25 | $-274.1M | $20.0M | ||
| Q2 25 | $-354.6M | $18.7M | ||
| Q1 25 | $-341.8M | $19.0M | ||
| Q4 24 | $-326.4M | $19.6M | ||
| Q3 24 | $-292.3M | $18.2M | ||
| Q2 24 | $-241.3M | $19.0M | ||
| Q1 24 | $-201.4M | $20.8M |
| Q4 25 | $226.8M | $107.8M | ||
| Q3 25 | $233.9M | $112.5M | ||
| Q2 25 | $185.2M | $105.8M | ||
| Q1 25 | $200.2M | $110.2M | ||
| Q4 24 | $226.3M | $119.4M | ||
| Q3 24 | $238.5M | $121.6M | ||
| Q2 24 | $292.4M | $124.2M | ||
| Q1 24 | $256.6M | $129.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-16.6M | $-1.1M |
| Free Cash FlowOCF − Capex | — | $-1.5M |
| FCF MarginFCF / Revenue | — | -5.0% |
| Capex IntensityCapex / Revenue | 0.0% | 1.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-6.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-16.6M | $-1.1M | ||
| Q3 25 | $-14.7M | $-178.0K | ||
| Q2 25 | $-20.2M | $1.1M | ||
| Q1 25 | $-25.6M | $-5.5M | ||
| Q4 24 | $-28.7M | $2.3M | ||
| Q3 24 | $-53.3M | $-4.8M | ||
| Q2 24 | $-38.2M | $6.2M | ||
| Q1 24 | $-38.2M | $-1.7M |
| Q4 25 | — | $-1.5M | ||
| Q3 25 | — | $-390.0K | ||
| Q2 25 | $-20.2M | $941.0K | ||
| Q1 25 | $-25.6M | $-5.5M | ||
| Q4 24 | $-28.7M | $1.9M | ||
| Q3 24 | $-53.3M | $-4.9M | ||
| Q2 24 | $-38.6M | $6.0M | ||
| Q1 24 | $-38.2M | $-2.0M |
| Q4 25 | — | -5.0% | ||
| Q3 25 | — | -1.4% | ||
| Q2 25 | -78.7% | 3.0% | ||
| Q1 25 | -106.5% | -18.8% | ||
| Q4 24 | -107.0% | 5.7% | ||
| Q3 24 | -212.2% | -13.8% | ||
| Q2 24 | -164.4% | 16.8% | ||
| Q1 24 | -136.5% | -5.7% |
| Q4 25 | 0.0% | 1.3% | ||
| Q3 25 | 0.0% | 0.7% | ||
| Q2 25 | 0.0% | 0.5% | ||
| Q1 25 | 0.0% | 0.0% | ||
| Q4 24 | 0.3% | 1.2% | ||
| Q3 24 | 0.0% | 0.4% | ||
| Q2 24 | 2.0% | 0.5% | ||
| Q1 24 | 0.1% | 0.9% |
| Q4 25 | — | — | ||
| Q3 25 | -0.23× | -0.34× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 17.13× | ||
| Q3 24 | — | -12.21× | ||
| Q2 24 | — | 385.25× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AGEN
| Non Cash Royalty Revenue | $31.1M | 91% |
| Other | $3.2M | 9% |
SYPR
| Sypris Electronics | $17.7M | 59% |
| Transferred At Point In Time | $12.5M | 41% |
